Clinical Pathology

In the latest round of AI funding, Israeli startup, Nucleai raised $5 million in seed round led by Vertex Ventures Israel and Grove Ventures Capital (GP) Ltd. Nucleai, a Tel Aviv-based startup, is developing an AI pathology system to help...

March 13, 2018 at 4pm GMT Register for this webinar: Click here Cancer care has evolved over time to precise, targeted & personalized therapy options. This evolution is primarily fueled by molecular pathology, which is now under pressure...

When: Tuesday, March 20, 5:00-7:30pm Where: Cactus Club Cafe, 1085 Canada Pl, Vancouver, BC Ready for Digital Diagnostics Pathology services are under pressure to meet the increasingly complex demands of cancer care. As the number of...

OR

platinum partners

gold partners

Silver Partners

Media Partners